Search Results
(3S,10R,13S,17R)-17-(3,3-Dimethoxypropyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol inquiry | Purity Not Available
Alfa Chemistry
(3S,10S,13R,14R,17R)-4,4,10,13,14-Pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol inquiry | Purity Not Available
Alfa Chemistry
(3S,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol Please inquire | Purity Not Available
BOC Sciences
(3S,10S,13R,14S,17R)-3,14-dihydroxy-13-methyl-17-(6-oxopyran-3-yl)-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthrene-10-carbaldehyde Please inquire | Purity Not Available
BOC Sciences
(3S,10S,13R,14S,17R)-3,14-Dihydroxy-13-methyl-17-(6-oxopyran-3-yl)-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthrene-10-carbaldehyde inquiry | Purity Not Available
Alfa Chemistry
(3S,10S,13R,14S)-3,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthrene-10-carbaldehyde Please inquire | Purity Not Available
BOC Sciences
(3S,10S,13R,14S)-3,14-Dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthrene-10-carbaldehyde inquiry | Purity Not Available
Alfa Chemistry
(3S,11AR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid 100mg | 97%
BLD Pharmatech Ltd.
(3S,11bS)-3-Isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one 1g | 95%
BLD Pharmatech Ltd.
(3S,11bS)-Tetrabenazine-[d6] Please inquire | >98%
BOC Sciences
(3S,11bS)-Tetrabenazine-[d6], is the labelled analogue of (3S,11bS)-Tetrabenazine. (3S,11bS)-Tetrabenazine is one of Tetrabenazine impurities. Tetrabenazine is a VMAT-inhibitor used for treatment of hyperkinetic movement disorder. It is a monoamine-depleting and a dopamine-receptor-blocking drug and is an effective and safe drug for the treatment of a variety of hyperkinetic movement disorders.
More Information Supplier Page

